Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
The Neurologist|September 12, 2008
Clinical comparisons of botulinum neurotoxin formulationsAllison BrashearExpert Opinion on Drug Safety|March 30, 2005
The safety and tolerability of botulinum toxins for the treatment of cervical dystoniaAllison BrashearExpert Review of Neurotherapeutics|October 9, 2009
Use of botulinum toxin type A in poststroke spasticityAllison BrashearBiologics : Targets & Therapy|August 27, 2009
Botulinum toxin type A in the treatment of patients with cervical dystoniaAllison BrashearBrain Communications|June 2, 2023
The vital role of natural history studies in rare disease: insights from X-linked dystonia parkinsonismIhtsham Haq, Allison BrashearThe Journal of Biological Chemistry|November 4, 2020
Misfolding, altered membrane distributions, and the unfolded protein response contribute to pathogenicity differences in Na,K-ATPase ATP1A3 mutationsElena Arystarkhova, Laurie J Ozelius, Allison Brashear, et al.Archives of Physical Medicine and Rehabilitation|May 7, 2004
Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trialAllison Brashear, Anita L McAfee, Elizabeth R Kuhn, et al.Toxins|July 12, 2017
Rehabilitation plus OnabotulinumtoxinA Improves Motor Function over OnabotulinumtoxinA Alone in Post-Stroke Upper Limb Spasticity: A Single-Blind, Randomized TrialDeidre Devier, JoAnn Harnar, Leandro Lopez, et al.Archives of Physical Medicine and Rehabilitation|February 18, 2003
Treatment with botulinum toxin type B for upper-limb spasticityAllison Brashear, Anita L McAfee, Elizabeth R Kuhn, et al.Pageof 7